Neurologist Dr. Kenichiro Ono discusses deep brain stimulation and treating epilepsy. Neurologist Dr. Kenichiro Ono talks about collaborating with researchers at Virginia Commonwealth University that ...

If your child has a seizure, it's natural to have plenty of concerns about what exactly happened, why, and what comes next. There are treatments that can help, but a lot depends on the cause of the ...

CAMBRIDGE, Mass. & BARCELONA, Spain--(BUSINESS WIRE)--Neuroelectrics, a clinical-stage company pioneering brain stimulation therapies, has been granted FDA Breakthrough Device Designation for its ...

The brain reinforces seizure networks during post-seizure sleep by hijacking the same mechanisms used for memory consolidation.

Please provide your email address to receive an email when new articles are posted on . XEN1101 is a novel small-molecule selective Kv7.2/Kv7.3 potassium channel opener. A 25 mg dose of XEN1101 ...

Please provide your email address to receive an email when new articles are posted on . Transdermal CBD was well tolerated and safe among those with drug-resistant focal epilepsy, although no efficacy ...

In focal epilepsy, seizures are generated by a localized, synchronous neuronal electrical discharge that may spread to large portions of the brain. In spite of intense research in the field of ...

Patients with focal epilepsy that does not respond to medications badly need alternative treatments. In a first-in-humans pilot study, researchers at the University of Alabama at Birmingham have ...

Prior to being diagnosed with epilepsy, 5% of people with a type of epilepsy called focal epilepsy had a seizure while driving, according to a new study published in the June 7, 2023, online issue of ...

Early detection of focal epilepsy may reduce the amount of motor vehicle accidents caused by seizures while driving. The prevalence of seizures while driving (SzWD) prior to diagnosis in people with ...

(RTTNews) - Shares of Xenon Pharmaceuticals Inc. (XENE) closed Monday's trading at an all-time high of $31.50, gaining more than 100%, thanks to promising mid-stage data for focal epilepsy drug ...